Global Rofecoxib Market Insights, Forecast to 2030

Publication ID:

PB512244225

Publication Date:

December 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Rofecoxib is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.Rofecoxib was available by prescription in both tablet-form and as an oral suspension.
The global Rofecoxib market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Rofecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Rofecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Rofecoxib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Rofecoxib include Merck, Chengdu Meinkai Chemical Co. LTD, Wuhan Xinxin Jiali Biotechnology Co. LTD, Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD, Pfizer and Tremeau, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Rofecoxib, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Rofecoxib, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Rofecoxib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Rofecoxib sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Rofecoxib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Rofecoxib sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau
Segment by Type
Oral Suspension.
Tablet-Form
Segment by Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Rofecoxib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Rofecoxib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rofecoxib sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Study Coverage
1.1 Rofecoxib Product Introduction
1.2 Market by Type
1.2.1 Global Rofecoxib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral Suspension.
1.2.3 Tablet-Form
1.3 Market by Application
1.3.1 Global Rofecoxib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Osteoarthritis
1.3.3 Rheumatoid Arthritis
1.3.4 Juvenile Rheumatoid Arthritis
1.3.5 Acute Pain Conditions
1.3.6 Migraine
1.3.7 Dysmenorrhea
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Rofecoxib Sales Estimates and Forecasts 2019-2030
2.2 Global Rofecoxib Revenue by Region
2.2.1 Global Rofecoxib Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Rofecoxib Revenue by Region (2019-2024)
2.2.3 Global Rofecoxib Revenue by Region (2025-2030)
2.2.4 Global Rofecoxib Revenue Market Share by Region (2019-2030)
2.3 Global Rofecoxib Sales Estimates and Forecasts 2019-2030
2.4 Global Rofecoxib Sales by Region
2.4.1 Global Rofecoxib Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Rofecoxib Sales by Region (2019-2024)
2.4.3 Global Rofecoxib Sales by Region (2025-2030)
2.4.4 Global Rofecoxib Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Rofecoxib Sales by Manufacturers
3.1.1 Global Rofecoxib Sales by Manufacturers (2019-2024)
3.1.2 Global Rofecoxib Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rofecoxib in 2023
3.2 Global Rofecoxib Revenue by Manufacturers
3.2.1 Global Rofecoxib Revenue by Manufacturers (2019-2024)
3.2.2 Global Rofecoxib Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Rofecoxib Revenue in 2023
3.3 Global Key Players of Rofecoxib, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Rofecoxib Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Rofecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Rofecoxib, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Rofecoxib, Product Offered and Application
3.8 Global Key Manufacturers of Rofecoxib, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rofecoxib Sales by Type
4.1.1 Global Rofecoxib Historical Sales by Type (2019-2024)
4.1.2 Global Rofecoxib Forecasted Sales by Type (2025-2030)
4.1.3 Global Rofecoxib Sales Market Share by Type (2019-2030)
4.2 Global Rofecoxib Revenue by Type
4.2.1 Global Rofecoxib Historical Revenue by Type (2019-2024)
4.2.2 Global Rofecoxib Forecasted Revenue by Type (2025-2030)
4.2.3 Global Rofecoxib Revenue Market Share by Type (2019-2030)
4.3 Global Rofecoxib Price by Type
4.3.1 Global Rofecoxib Price by Type (2019-2024)
4.3.2 Global Rofecoxib Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Rofecoxib Sales by Application
5.1.1 Global Rofecoxib Historical Sales by Application (2019-2024)
5.1.2 Global Rofecoxib Forecasted Sales by Application (2025-2030)
5.1.3 Global Rofecoxib Sales Market Share by Application (2019-2030)
5.2 Global Rofecoxib Revenue by Application
5.2.1 Global Rofecoxib Historical Revenue by Application (2019-2024)
5.2.2 Global Rofecoxib Forecasted Revenue by Application (2025-2030)
5.2.3 Global Rofecoxib Revenue Market Share by Application (2019-2030)
5.3 Global Rofecoxib Price by Application
5.3.1 Global Rofecoxib Price by Application (2019-2024)
5.3.2 Global Rofecoxib Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Rofecoxib Market Size by Type
6.1.1 US & Canada Rofecoxib Sales by Type (2019-2030)
6.1.2 US & Canada Rofecoxib Revenue by Type (2019-2030)
6.2 US & Canada Rofecoxib Market Size by Application
6.2.1 US & Canada Rofecoxib Sales by Application (2019-2030)
6.2.2 US & Canada Rofecoxib Revenue by Application (2019-2030)
6.3 US & Canada Rofecoxib Market Size by Country
6.3.1 US & Canada Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Rofecoxib Sales by Country (2019-2030)
6.3.3 US & Canada Rofecoxib Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Rofecoxib Market Size by Type
7.1.1 Europe Rofecoxib Sales by Type (2019-2030)
7.1.2 Europe Rofecoxib Revenue by Type (2019-2030)
7.2 Europe Rofecoxib Market Size by Application
7.2.1 Europe Rofecoxib Sales by Application (2019-2030)
7.2.2 Europe Rofecoxib Revenue by Application (2019-2030)
7.3 Europe Rofecoxib Market Size by Country
7.3.1 Europe Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Rofecoxib Sales by Country (2019-2030)
7.3.3 Europe Rofecoxib Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Rofecoxib Market Size
8.1.1 China Rofecoxib Sales (2019-2030)
8.1.2 China Rofecoxib Revenue (2019-2030)
8.2 China Rofecoxib Market Size by Application
8.2.1 China Rofecoxib Sales by Application (2019-2030)
8.2.2 China Rofecoxib Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Rofecoxib Market Size by Type
9.1.1 Asia Rofecoxib Sales by Type (2019-2030)
9.1.2 Asia Rofecoxib Revenue by Type (2019-2030)
9.2 Asia Rofecoxib Market Size by Application
9.2.1 Asia Rofecoxib Sales by Application (2019-2030)
9.2.2 Asia Rofecoxib Revenue by Application (2019-2030)
9.3 Asia Rofecoxib Sales by Region
9.3.1 Asia Rofecoxib Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Rofecoxib Revenue by Region (2019-2030)
9.3.3 Asia Rofecoxib Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Rofecoxib Market Size by Type
10.1.1 Middle East, Africa and Latin America Rofecoxib Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Rofecoxib Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Rofecoxib Market Size by Application
10.2.1 Middle East, Africa and Latin America Rofecoxib Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Rofecoxib Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Rofecoxib Sales by Country
10.3.1 Middle East, Africa and Latin America Rofecoxib Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Rofecoxib Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Rofecoxib Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Merck Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Chengdu Meinkai Chemical Co. LTD
11.2.1 Chengdu Meinkai Chemical Co. LTD Company Information
11.2.2 Chengdu Meinkai Chemical Co. LTD Overview
11.2.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Chengdu Meinkai Chemical Co. LTD Recent Developments
11.3 Wuhan Xinxin Jiali Biotechnology Co. LTD
11.3.1 Wuhan Xinxin Jiali Biotechnology Co. LTD Company Information
11.3.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Overview
11.3.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Developments
11.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
11.4.1 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Information
11.4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Overview
11.4.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pfizer Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Tremeau
11.6.1 Tremeau Company Information
11.6.2 Tremeau Overview
11.6.3 Tremeau Rofecoxib Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Tremeau Rofecoxib Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Tremeau Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rofecoxib Industry Chain Analysis
12.2 Rofecoxib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rofecoxib Production Mode & Process
12.4 Rofecoxib Sales and Marketing
12.4.1 Rofecoxib Sales Channels
12.4.2 Rofecoxib Distributors
12.5 Rofecoxib Customers
13 Market Dynamics
13.1 Rofecoxib Industry Trends
13.2 Rofecoxib Market Drivers
13.3 Rofecoxib Market Challenges
13.4 Rofecoxib Market Restraints
14 Key Findings in The Global Rofecoxib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Companies Mentioned:

Merck
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Pfizer
Tremeau

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂